Medilink Midlands will be hosting a webinar with the Office for Life Sciences (OLS), who will present on everything medtech firms need to know about at the end of the Brexit transition period.
This webinar, taking place on Wednesday 4 November, will cover:
- The latest on Trade Negotiations with the European Union, as well as the United States and Australia.
- How the regulation of medtech is changing from the 1 January, what your business needs to get ready, and how the UK will develop a new sovereign system.
- How the border, imports and exports will work from 1 January; and
- Action that firms need to take on data, immigration and global recruitment, and EU research funding.
The session will include a Q&A session, as well as guidance on where to go for further information, support and advice.
Speakers will include Alex Mclaughlin, head of international trade and medical device regulation, OLS, and Jess Kirby, senior policy advisor, international trade and medical devices, OLS.
McLaughlin is responsible for all of OLS’s work on International Trade and Medical Device Regulation, advising ministers in the Business and Health Departments.
Prior to his current role, McLaughlin was senior private secretary to two health ministers, established the Department’s epidemic vaccines programme, and worked for the chief medical officer.
Kirby is a trade and medical device expert, who has worked in the Business Department for three years – with roles focussed on Brexit and International Trade.
Prior to this, Kirby trained as an NHS radiographer and worked in a specialist medical device firm.
You can register for the webinar, here.
